Product Name

  • Name

    Colchicine

  • EINECS 200-598-5
  • CAS No. 64-86-8
  • Article Data23
  • CAS DataBase
  • Density 1.25 g/cm3
  • Solubility 45 g/L (20 °C) in water
  • Melting Point 150-160 °C (dec.)(lit.)
  • Formula C22H25NO6
  • Boiling Point 726 °C at 760 mmHg
  • Molecular Weight 399.444
  • Flash Point 392.9 °C
  • Transport Information UN 1544 6.1/PG 1
  • Appearance Yellow solid
  • Safety 13-45
  • Risk Codes 26/28
  • Molecular Structure Molecular Structure of 64-86-8 (Colchicine)
  • Hazard Symbols ToxicT, VeryT+
  • Synonyms Acetamide,N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)-;Colchicine (8CI);(-)-Colchicine;(S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide;Colchineos;Colchisol;Colcin;Colsaloid;Condylon;NSC 757;
  • PSA 83.09000
  • LogP 3.26250

Synthetic route

acetic anhydride
108-24-7

acetic anhydride

(S)-tert-butyl N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalene-7-yl)carbamate
186374-95-8

(S)-tert-butyl N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalene-7-yl)carbamate

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Stage #1: (S)-tert-butyl N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalene-7-yl)carbamate With hydrogenchloride In diethyl ether at 20℃; for 1h;
Stage #2: acetic anhydride With dmap; triethylamine In diethyl ether at 25℃; for 10h;
98%
methoxymagnesium bromide

methoxymagnesium bromide

10-demethoxy-10-tosylcolchicine

10-demethoxy-10-tosylcolchicine

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
In tetrahydrofuran for 5h;85%
C22H27NO7

C22H27NO7

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
With N,N-dimethyl-ethanamine; trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 12h; Inert atmosphere;81%
With N,N-dimethyl-ethanamine; trimethylsilyl trifluoromethanesulfonate In dichloromethane81%
With trimethylsilyl trifluoromethanesulfonate; triethylamine In dichloromethane at 20℃; for 2h;75%
magnesium methanolate
109-88-6, 16436-83-2, 16436-85-4

magnesium methanolate

10-demethoxy-10-tosylcolchicine

10-demethoxy-10-tosylcolchicine

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
In methanol78%
diethyl ether
60-29-7

diethyl ether

chloroform
67-66-3

chloroform

A

colchicine
64-86-8

colchicine

B

(7S)-isocolchicine
518-12-7

(7S)-isocolchicine

A

colchicine
64-86-8

colchicine

B

(7S)-isocolchicine
518-12-7

(7S)-isocolchicine

Conditions
ConditionsYield
With diethyl ether; chloroform
2,10-didemethylcolchicine
33530-04-0

2,10-didemethylcolchicine

A

colchicine
64-86-8

colchicine

B

2-demethylcolchicine
7336-36-9

2-demethylcolchicine

C

(7S)-isocolchicine
518-12-7

(7S)-isocolchicine

D

2-demethylisocolchicine
142713-50-6

2-demethylisocolchicine

Conditions
ConditionsYield
In diethyl ether; chloroform
<1-3H>-3-phenylpropanal
133946-40-4

<1-3H>-3-phenylpropanal

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Colchicum byzantinum biosynthesis;
<3-14C>-cinnamic acid
4469-06-1

<3-14C>-cinnamic acid

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Colchicum byzantinum biosynthesis;
deacetylcolchicine
3476-50-4

deacetylcolchicine

acetic anhydride
108-24-7

acetic anhydride

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
With sodium hydrogencarbonate In chloroform; water for 2.5h;
Acetylation;
<1-3H>-3-phenylprop-2-enal
133946-39-1

<1-3H>-3-phenylprop-2-enal

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Colchicum byzantinum biosynthesis;
<3-14C>-3-phenylpropionic acid
131946-50-4

<3-14C>-3-phenylpropionic acid

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Colchicum byzantinum biosynthesis;
DL-phenylalanine
13744-69-9

DL-phenylalanine

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Colchicum byzantinum biosynthesis;
colchicine-β-cyclodextrin complex

colchicine-β-cyclodextrin complex

A

colchicine
64-86-8

colchicine

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
at 25 - 60℃; Equilibrium constant;
(-)-O2-demethyl-colchicine

(-)-O2-demethyl-colchicine

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
With methanol; diethyl ether
(-)-O3-demethyl-colchicine

(-)-O3-demethyl-colchicine

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
With methanol; diethyl ether
3-(3,4,5-trimethoxyphenyl)propan-1-ol
53560-26-2

3-(3,4,5-trimethoxyphenyl)propan-1-ol

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 17 steps
1.1: 98 percent / 2,6-lutidine / CH2Cl2 / 5 h / 20 °C
2.1: 95 percent / silver trifluoroacetate; I2; sodium bicarbonate / CHCl3 / 3 h / 0 °C
3.1: 92 percent / Et2NH; bis[triphenylphosphine]palladium dichloride; copper(I) iodide / dimethylsulfoxide / 20 h / 90 °C
4.1: 98 percent / n-Bu4NF / tetrahydrofuran / 7 h / 20 °C
5.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.75 h / -78 °C
6.1: BH3*THF / tetrahydrofuran / 1 h / 20 °C
6.2: t-BuLi / pentane; tetrahydrofuran / 0.67 h / -78 °C
6.3: 64 percent / tetrahydrofuran; pentane / 3 h / -78 °C
7.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C
8.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C
9.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C
10.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C
11.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C
12.1: 60 percent / various solvent(s) / 66 h / Heating
13.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
14.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
15.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
16.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
17.1: HCl / diethyl ether / 1 h / 20 °C
17.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 18 steps
1: 2,6-lutidine
2: I2; CF3CO2Ag / CHCl3
3: Et2NH; CuI / (Ph3P)2PdCl2 / dimethylsulfoxide
4: TBAF / tetrahydrofuran
5: (COCl)2; DMSO; Et3N
7: (COCl)2; DMSO; Et3N
9: 64 percent / PPh3; DEAD; (PhO)2P(O)N3
10: Ph3P; H2O
11: Et3N
12: 70 percent / 1,2-dichloro-benzene / Heating
13: LiOH
15: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
16: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
17: HCl
View Scheme
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 15 steps
1.1: zinc-copper couple / benzene; N,N-dimethyl-acetamide / 3 h / 20 °C / sonication
1.2: 31 percent / bis(triphenylphosphine)palladium dichloride / benzene; N,N-dimethyl-acetamide / 2 h / sonication
2.1: 91 percent / H2 / Pd/C / ethanol; H2O / 22 h / 3102.89 Torr
3.1: 93 percent / NaHCO3; silver trifluoroacetate; I2 / CHCl3 / 2 h / 0 °C
4.1: trifluoroacetic acid / diethyl ether / 3 h / 20 °C
5.1: 454 mg / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h
6.1: 60 percent / Et2NH; bis[triphenylphosphine]palladium dichloride; copper(I) iodide / dimethylsulfoxide / 15 h / 90 °C
7.1: 91 percent / potassium carbonate / methanol / 11 h / 20 °C
8.1: 100 percent / DIBAL / CH2Cl2; hexane / 1 h / -78 °C
9.1: potassium carbonate / methanol / 1 h / Heating
9.2: 64 percent / KOH / methanol / 3 h / Heating
10.1: 70 percent / various solvent(s) / 40 h / Heating
11.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
12.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
13.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
14.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
15.1: HCl / diethyl ether / 1 h / 20 °C
15.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
3-(2-ethynyl-3,4,5-trimethoxy-phenyl)-propionaldehyde
327024-99-7

3-(2-ethynyl-3,4,5-trimethoxy-phenyl)-propionaldehyde

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1.1: BH3*THF / tetrahydrofuran / 1 h / 20 °C
1.2: t-BuLi / pentane; tetrahydrofuran / 0.67 h / -78 °C
1.3: 64 percent / tetrahydrofuran; pentane / 3 h / -78 °C
2.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C
3.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C
4.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C
5.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C
6.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C
7.1: 60 percent / various solvent(s) / 66 h / Heating
8.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
9.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
10.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
11.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
12.1: HCl / diethyl ether / 1 h / 20 °C
12.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 13 steps
2: (COCl)2; DMSO; Et3N
4: 64 percent / PPh3; DEAD; (PhO)2P(O)N3
5: Ph3P; H2O
6: Et3N
7: 70 percent / 1,2-dichloro-benzene / Heating
8: LiOH
10: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
11: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
12: HCl
View Scheme
3-(2-ethynyl-3,4,5-trimethoxyphenyl)propan-1-ol
206195-25-7

3-(2-ethynyl-3,4,5-trimethoxyphenyl)propan-1-ol

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 13 steps
1.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.75 h / -78 °C
2.1: BH3*THF / tetrahydrofuran / 1 h / 20 °C
2.2: t-BuLi / pentane; tetrahydrofuran / 0.67 h / -78 °C
2.3: 64 percent / tetrahydrofuran; pentane / 3 h / -78 °C
3.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C
4.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C
5.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C
6.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C
7.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C
8.1: 60 percent / various solvent(s) / 66 h / Heating
9.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
10.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
11.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
12.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
13.1: HCl / diethyl ether / 1 h / 20 °C
13.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 14 steps
1: (COCl)2; DMSO; Et3N
3: (COCl)2; DMSO; Et3N
5: 64 percent / PPh3; DEAD; (PhO)2P(O)N3
6: Ph3P; H2O
7: Et3N
8: 70 percent / 1,2-dichloro-benzene / Heating
9: LiOH
11: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
12: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
13: HCl
View Scheme
3-(2-ethynyl-3,4,5-trimethoxy-phenyl)-1-oxazol-2-yl-propan-1-one

3-(2-ethynyl-3,4,5-trimethoxy-phenyl)-1-oxazol-2-yl-propan-1-one

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C
2.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C
3.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C
4.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C
5.1: 60 percent / various solvent(s) / 66 h / Heating
6.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
7.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
8.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
9.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
10.1: HCl / diethyl ether / 1 h / 20 °C
10.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 11 steps
2: 64 percent / PPh3; DEAD; (PhO)2P(O)N3
3: Ph3P; H2O
4: Et3N
5: 70 percent / 1,2-dichloro-benzene / Heating
6: LiOH
8: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
9: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
10: HCl
View Scheme
3-(2-ethynyl-3,4,5-trimethoxyphenyl)-1-(1,3-oxazol-2-yl)propan-1-ol
206195-28-0

3-(2-ethynyl-3,4,5-trimethoxyphenyl)-1-(1,3-oxazol-2-yl)propan-1-ol

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C
2.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C
3.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C
4.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C
5.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C
6.1: 60 percent / various solvent(s) / 66 h / Heating
7.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
8.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
9.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
10.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
11.1: HCl / diethyl ether / 1 h / 20 °C
11.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 12 steps
1: (COCl)2; DMSO; Et3N
3: 64 percent / PPh3; DEAD; (PhO)2P(O)N3
4: Ph3P; H2O
5: Et3N
6: 70 percent / 1,2-dichloro-benzene / Heating
7: LiOH
9: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
10: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
11: HCl
View Scheme
triisopropyl-[3-(3,4,5-trimethoxy-phenyl)-propoxy]-silane
327025-17-2

triisopropyl-[3-(3,4,5-trimethoxy-phenyl)-propoxy]-silane

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 16 steps
1.1: 95 percent / silver trifluoroacetate; I2; sodium bicarbonate / CHCl3 / 3 h / 0 °C
2.1: 92 percent / Et2NH; bis[triphenylphosphine]palladium dichloride; copper(I) iodide / dimethylsulfoxide / 20 h / 90 °C
3.1: 98 percent / n-Bu4NF / tetrahydrofuran / 7 h / 20 °C
4.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.75 h / -78 °C
5.1: BH3*THF / tetrahydrofuran / 1 h / 20 °C
5.2: t-BuLi / pentane; tetrahydrofuran / 0.67 h / -78 °C
5.3: 64 percent / tetrahydrofuran; pentane / 3 h / -78 °C
6.1: 96 percent / oxalyl chloride; DMSO / CH2Cl2 / 0.5 h / -78 °C
7.1: 85 percent / BH3*THF; (S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol / tetrahydrofuran / 6 h / 23 °C
8.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C
9.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C
10.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C
11.1: 60 percent / various solvent(s) / 66 h / Heating
12.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
13.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
14.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
15.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
16.1: HCl / diethyl ether / 1 h / 20 °C
16.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 17 steps
1: I2; CF3CO2Ag / CHCl3
2: Et2NH; CuI / (Ph3P)2PdCl2 / dimethylsulfoxide
3: TBAF / tetrahydrofuran
4: (COCl)2; DMSO; Et3N
6: (COCl)2; DMSO; Et3N
8: 64 percent / PPh3; DEAD; (PhO)2P(O)N3
9: Ph3P; H2O
10: Et3N
11: 70 percent / 1,2-dichloro-benzene / Heating
12: LiOH
14: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
15: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
16: HCl
View Scheme
5-[(3S)-3-azido-3-(1,3-oxazol-2-yl)propyl]-4-ethynyl-1,2,3-trimethoxybenzene
206195-32-6

5-[(3S)-3-azido-3-(1,3-oxazol-2-yl)propyl]-4-ethynyl-1,2,3-trimethoxybenzene

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C
2.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C
3.1: 60 percent / various solvent(s) / 66 h / Heating
4.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
5.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
6.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
7.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
8.1: HCl / diethyl ether / 1 h / 20 °C
8.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 9 steps
1: Ph3P; H2O
2: Et3N
3: 70 percent / 1,2-dichloro-benzene / Heating
4: LiOH
6: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
7: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
8: HCl
View Scheme
(S)-3-(2-Ethynyl-3,4,5-trimethoxy-phenyl)-1-oxazol-2-yl-propylamine
327024-98-6

(S)-3-(2-Ethynyl-3,4,5-trimethoxy-phenyl)-1-oxazol-2-yl-propylamine

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C
2.1: 60 percent / various solvent(s) / 66 h / Heating
3.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
4.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
5.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
6.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
7.1: HCl / diethyl ether / 1 h / 20 °C
7.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 8 steps
1: Et3N
2: 70 percent / 1,2-dichloro-benzene / Heating
3: LiOH
5: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
6: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
7: HCl
View Scheme
(1R)-3-(2-ethynyl-3,4,5-trimethoxyphenyl)-1-(1,3-oxazol-2-yl)propan-1-ol
206195-30-4

(1R)-3-(2-ethynyl-3,4,5-trimethoxyphenyl)-1-(1,3-oxazol-2-yl)propan-1-ol

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: 60 percent / diphenylphosphoryl azide; triphenylphosphine; diisopropylazodicarboxylate / tetrahydrofuran / 12 h / 20 °C
2.1: 95 percent / Ph3P / tetrahydrofuran; H2O / 50 h / 20 °C
3.1: 98 percent / DMAP; Et3N / diethyl ether / 7 h / 20 °C
4.1: 60 percent / various solvent(s) / 66 h / Heating
5.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
6.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
7.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
8.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
9.1: HCl / diethyl ether / 1 h / 20 °C
9.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 10 steps
1: 64 percent / PPh3; DEAD; (PhO)2P(O)N3
2: Ph3P; H2O
3: Et3N
4: 70 percent / 1,2-dichloro-benzene / Heating
5: LiOH
7: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
8: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
9: HCl
View Scheme
(S)-N-7-acetylamino-12,13,14-trimethoxy-5-oxatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),3,11,13-pentaene
206195-21-3

(S)-N-7-acetylamino-12,13,14-trimethoxy-5-oxatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),3,11,13-pentaene

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
2.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
3.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
4.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
5.1: HCl / diethyl ether / 1 h / 20 °C
5.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 6 steps
1: LiOH
3: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
4: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
5: HCl
View Scheme
(S)-N-acetyl-3-(2-ethynyl-3,4,5-trimethoxyphenyl)-1-(2-oxazolyl)-propylamine
206195-23-5

(S)-N-acetyl-3-(2-ethynyl-3,4,5-trimethoxyphenyl)-1-(2-oxazolyl)-propylamine

colchicine
64-86-8

colchicine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: 60 percent / various solvent(s) / 66 h / Heating
2.1: 99 percent / Et3N; 4-(dimethylamino)pyridine / CH2Cl2 / 10 h / 35 °C
3.1: 99 percent / aq. LiOH / tetrahydrofuran / 12 h
4.1: 45 percent Turnov. / trimethylsilyltriflate / various solvent(s) / -78 - -60 °C
5.1: 62 percent / Et3N; trimethylsilyl triflate / CH2Cl2 / 2 h / 0 °C
6.1: HCl / diethyl ether / 1 h / 20 °C
6.2: 98 percent / 4-(dimethylamino)pyridine; Et3N / diethyl ether / 10 h / 25 °C
View Scheme
Multi-step reaction with 7 steps
1: 70 percent / 1,2-dichloro-benzene / Heating
2: LiOH
4: 45 percent / TMSOTf / various solvent(s) / -78 - -50 °C
5: 62 percent / TMSOTf; Et3N / CH2Cl2 / 0 - 10 °C
6: HCl
View Scheme
colchicine
64-86-8

colchicine

N-[(7S)-1,2,3-trimethoxy-9-oxo-10-amino-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
3123-89-5

N-[(7S)-1,2,3-trimethoxy-9-oxo-10-amino-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide

Conditions
ConditionsYield
With ammonium hydroxide In ethanol for 12h; Reflux;100%
With ammonium hydroxide In methanol at 20℃;90%
With ammonium hydroxide In ethanol at 110℃; for 0.25h; Microwave irradiation;75%
colchicine
64-86-8

colchicine

allocolchicinic acid
6714-14-3

allocolchicinic acid

Conditions
ConditionsYield
With sodium methylate In methanol at 65℃; for 4h;100%
With methanol; sodium methylate In water at 65℃;99%
With methanol; water; sodium methylate
Dichloromethyl methyl ether
4885-02-3

Dichloromethyl methyl ether

colchicine
64-86-8

colchicine

4-Formylcolchicine
2730-82-7

4-Formylcolchicine

Conditions
ConditionsYield
With tin(IV) chloride In dichloromethane100%
With tin(IV) chloride In dichloromethane at 20℃; for 13h; Cooling with ice; Inert atmosphere;100%
With tin(IV) chloride In dichloromethane 0 deg C, 30 min., r.t. 15 h;90%
With tin(IV) chloride In dichloromethane at 20℃;
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

colchicine
64-86-8

colchicine

(S)-tert-butyl-N-acetyl(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalene-7-yl)carbamate
186374-94-7

(S)-tert-butyl-N-acetyl(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalene-7-yl)carbamate

Conditions
ConditionsYield
With dmap; triethylamine In acetonitrile at 100℃; for 7.5h;100%
With dmap; triethylamine In acetonitrile at 100℃; Inert atmosphere;98%
With dmap; triethylamine In tetrahydrofuran for 2h; Reflux;97.5%
formaldehyd
50-00-0

formaldehyd

colchicine
64-86-8

colchicine

urethane
51-79-6

urethane

ethyl {[(7S)-7-(acetylamino)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-4-yl]methyl}carbamate

ethyl {[(7S)-7-(acetylamino)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-4-yl]methyl}carbamate

Conditions
ConditionsYield
Stage #1: formaldehyd; urethane With sulfuric acid; water at 20℃; for 0.166667h;
Stage #2: colchicine at 20℃; for 4h;
99%
colchicine
64-86-8

colchicine

4-Bromocolchicine
1267993-28-1

4-Bromocolchicine

Conditions
ConditionsYield
With N-Bromosuccinimide; acetic acid99%
With N-Bromosuccinimide; acetic acid; trifluoroacetic acid at 20℃; for 1h; Schlenk technique; Inert atmosphere;95%
With N-Bromosuccinimide; acetic acid; trifluoroacetic acid In trifluoroacetic acid at 20℃; for 1h; Schlenk technique; Inert atmosphere;95%
colchicine
64-86-8

colchicine

4-Iodocolchicine
1267993-31-6

4-Iodocolchicine

Conditions
ConditionsYield
With N-iodo-succinimide; acetic acid99%
With N-iodo-succinimide; acetic acid at 70℃; for 7h; Time; Inert atmosphere;98.6%
With N-iodo-succinimide; acetic acid In acetonitrile at 70℃; for 20h; Inert atmosphere;95%
With N-iodo-succinimide; acetic acid at 70℃; for 20h; Inert atmosphere;95%
With N-iodo-succinimide; acetic acid at 70℃; for 7h;
[(S)-1-(2-aminoethyl)-pyrrolidin-2-yl]methanol
115531-70-9

[(S)-1-(2-aminoethyl)-pyrrolidin-2-yl]methanol

colchicine
64-86-8

colchicine

C28H37N3O6
1415569-02-6

C28H37N3O6

Conditions
ConditionsYield
In dichloromethane at 70℃; for 4h;99%
[(2R)-1-(2-aminoethyl)pyrrolidin-2-yl]methanol
867008-77-3

[(2R)-1-(2-aminoethyl)pyrrolidin-2-yl]methanol

colchicine
64-86-8

colchicine

C28H37N3O6
1415569-03-7

C28H37N3O6

Conditions
ConditionsYield
In dichloromethane at 70℃; for 4h;99%
colchicine
64-86-8

colchicine

Conditions
ConditionsYield
With hydrogenchloride; acetic acid In water at 100℃; for 3h;98%
With hydrogenchloride; acetic acid In water at 100℃; for 3h;98%
With hydrogenchloride; acetic acid at 100℃; for 3h;98%
colchicine
64-86-8

colchicine

ethanolamine
141-43-5

ethanolamine

N-[(S)-10-(2-hydroxy-ethylamino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl]-acetamide
55340-40-4

N-[(S)-10-(2-hydroxy-ethylamino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl]-acetamide

Conditions
ConditionsYield
In dichloromethane at 70℃; for 4h;98%
In ethanol at 20℃; for 48h;90%
8-Aminooctanoic acid
1002-57-9

8-Aminooctanoic acid

colchicine
64-86-8

colchicine

C29H38N2O7

C29H38N2O7

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water for 24h;96%
colchicine
64-86-8

colchicine

C22H25NO6*Li(1+)

C22H25NO6*Li(1+)

Conditions
ConditionsYield
With lithium nitrate In methanol at 20℃; for 24h;96%
colchicine
64-86-8

colchicine

sodium thiomethoxide
5188-07-8

sodium thiomethoxide

thiocolchicine
2730-71-4

thiocolchicine

Conditions
ConditionsYield
In water for 1h; Heating;95%
In methanol; water at 20℃; for 72h;78%
In methanol; water at 20℃; for 72h;78%
colchicine
64-86-8

colchicine

benzamidin
618-39-3

benzamidin

(S)-N-(5,6,7,8a-tetrahydro-1,2,3-trimethoxy-10-phenylbenzo[6,7]heptaleno[2,3-d]imidazol-7-yl)acetamide

(S)-N-(5,6,7,8a-tetrahydro-1,2,3-trimethoxy-10-phenylbenzo[6,7]heptaleno[2,3-d]imidazol-7-yl)acetamide

Conditions
ConditionsYield
In benzene at 20℃; for 24h; Condensation; substitution;95%
colchicine
64-86-8

colchicine

1-(2-aminoethyl)piperidin-3-ol
847499-95-0

1-(2-aminoethyl)piperidin-3-ol

C28H37N3O6
1415569-00-4

C28H37N3O6

Conditions
ConditionsYield
In dichloromethane at 70℃; for 4h;95%
colchicine
64-86-8

colchicine

ethylenediamine
107-15-3

ethylenediamine

(S)-N-(10-((2-aminoethyl)amino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo [a]heptalen-7-yl acetamide)
67620-27-3

(S)-N-(10-((2-aminoethyl)amino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo [a]heptalen-7-yl acetamide)

Conditions
ConditionsYield
In dichloromethane at 70℃; for 4h;95%
colchicine
64-86-8

colchicine

C22H25NO6*Rb(1+)*I(1-)

C22H25NO6*Rb(1+)*I(1-)

Conditions
ConditionsYield
With rubidium iodide In methanol95%
colchicine
64-86-8

colchicine

C22H25NO6*Rb(1+)*ClO4(1-)

C22H25NO6*Rb(1+)*ClO4(1-)

Conditions
ConditionsYield
With rubidium perchlorate In methanol95%
colchicine
64-86-8

colchicine

C22H25NO6*Na(1+)*NO3(1-)

C22H25NO6*Na(1+)*NO3(1-)

Conditions
ConditionsYield
With sodium nitrate In methanol at 20℃; for 24h;95%
colchicine
64-86-8

colchicine

C22H25NO6*K(1+)*NO3(1-)

C22H25NO6*K(1+)*NO3(1-)

Conditions
ConditionsYield
With potassium nitrate In methanol at 20℃; for 24h;95%
colchicine
64-86-8

colchicine

benzylamine
100-46-9

benzylamine

N-<5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxo-10-<(phenylmethyl)amino>benzoheptalen-7-yl>-(S)-acetamide
76129-15-2

N-<5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxo-10-<(phenylmethyl)amino>benzoheptalen-7-yl>-(S)-acetamide

Conditions
ConditionsYield
In ethanol at 116℃; for 20h;94%
at 20℃; for 72h;80%
With ethanol
colchicine
64-86-8

colchicine

C22H25NO6*Cs(1+)*I(1-)

C22H25NO6*Cs(1+)*I(1-)

Conditions
ConditionsYield
With cesium iodide In methanol94%
colchicine
64-86-8

colchicine

C22H25NO6*Mg(2+)*2NO3(1-)

C22H25NO6*Mg(2+)*2NO3(1-)

Conditions
ConditionsYield
With magnesium(II) nitrate In methanol at 20℃; for 24h;94%
colchicine
64-86-8

colchicine

(aR,5S)-N-(3-hydroxy-2-iodo-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cycloheptene-5-yl)-acetamide
38838-27-6

(aR,5S)-N-(3-hydroxy-2-iodo-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cycloheptene-5-yl)-acetamide

Conditions
ConditionsYield
Stage #1: colchicine With hydrogenchloride; acetic acid In water at 100℃; for 3h;
Stage #2: With iodine; potassium iodide; sodium hydroxide In water at 0 - 5℃; for 1h;
93%
Stage #1: colchicine With hydrogenchloride; acetic acid at 100℃; for 3h;
Stage #2: With iodine; potassium iodide; sodium hydroxide In water at 0 - 5℃; for 2h;
91%
Stage #1: colchicine With hydrogenchloride; acetic acid at 100℃; for 3h;
Stage #2: With iodine; potassium iodide; sodium hydroxide In water at 0 - 5℃; for 2h;
88%
colchicine
64-86-8

colchicine

C22H25NO6*Cs(1+)*ClO4(1-)

C22H25NO6*Cs(1+)*ClO4(1-)

Conditions
ConditionsYield
With cesium perchlorate In methanol93%
colchicine
64-86-8

colchicine

diethylamine
109-89-7

diethylamine

N-[(7S)-1,2,3-trimethoxy-9-oxo-10-(diethylamino)-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
6962-03-4

N-[(7S)-1,2,3-trimethoxy-9-oxo-10-(diethylamino)-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide

Conditions
ConditionsYield
In dichloromethane; acetonitrile for 24h; Reflux; regioselective reaction;92%
In ethanol at 20℃; for 48h;90%
In methanol at 20℃;75%
colchicine
64-86-8

colchicine

N-(10-amino-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl)-acetamide

N-(10-amino-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl)-acetamide

Conditions
ConditionsYield
With ammonium hydroxide Substitution;90%
colchicine
64-86-8

colchicine

di-n-propylamine
142-84-7

di-n-propylamine

C27H36N2O5

C27H36N2O5

Conditions
ConditionsYield
In dichloromethane; acetonitrile for 24h; Reflux; regioselective reaction;90%

Colchicine Chemical Properties


IUPAC: N-[(7S)-1,2,3,10-Tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
Molecular Formula:C22H25NO6
Molecular Weight:399.44
EINECS:200-598-5
Melting Point:150-160 °C (dec.)(lit.)
Solubility: H2O: 10 mg/mL
Form:Powder
Color:White to yellow with a green cast
Water Solubility:45 g/L (20 °C)
Classification Code: Agricultural Chemical; Antimitotic Agents; Antirheumatic Agents; Drug / Therapeutic Agent; Gout suppressants; Human Data; Mitosis Modulators; Mutation data; Reproductive Effect; Skin / Eye Irritant; Suppressant [gout]; Tubulin Modulators
Index of Refraction: 1.584 
Molar Refractivity: 106.6 cm3 
Molar Volume: 318.1 cm3
Surface Tension: 50.5 dyne/cm 
Density: 1.25 g/cm3 
Flash Point: 392.9 °C 
Enthalpy of Vaporization: 106.01 kJ/mol 
Boiling Point: 726 °C at 760 mmHg  
Vapour Pressure of Colchicine (CAS NO.64-86-8): 6.21E-21 mmHg at 25 °C

Colchicine Uses

Colchicine(64-86-8) is used as an antimitotic agent that disrupts microtubles by binding to tubulin and preventing its polymerization. Stimulates the intrinsic GTPase activity of tubulin. Induces apoptosis in several normal and tumor cell lines and activates the JNK/SAPK signal.

Colchicine Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
bird - wild LD50 oral 31600ug/kg (31.6mg/kg)   Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983.
cat LD50 intravenous 250ug/kg (0.25mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: NAUSEA OR VOMITING
Journal of Pharmacology and Experimental Therapeutics. Vol. 106, Pg. 261, 1952.
cat LDLo oral 125ug/kg (0.125mg/kg)   "Principles of Insect Chemosterilization," Labrecque, G.C., and C.N. Smith, eds., New York, Appleton-Century-Crofts, 1968Vol. -, Pg. 315, 1968.
cat LDLo subcutaneous 500ug/kg (0.5mg/kg)   "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1337, 1935.
child TDLo parenteral 2400ug/kg (2.4mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

GASTROINTESTINAL: NAUSEA OR VOMITING

BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE
Veterinary and Human Toxicology. Vol. 37, Pg. 366, 1995.
dog LDLo oral 125ug/kg (0.125mg/kg)   "Principles of Insect Chemosterilization," Labrecque, G.C., and C.N. Smith, eds., New York, Appleton-Century-Crofts, 1968Vol. -, Pg. 315, 1968.
dog LDLo subcutaneous 571ug/kg (0.571mg/kg)   "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1337, 1935.
dog LDLo unreported 5mg/kg (5mg/kg)   Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 27, Pg. 119, 1890.
gerbil LD50 intraperitoneal 90mg/kg (90mg/kg)   Medicina et Pharmacologia Experimentalis. Vol. 17, Pg. 323, 1967.
guinea pig LD50 intraperitoneal 500ug/kg (0.5mg/kg)   Medicina Experimentalis. Vol. 6, Pg. 101, 1962.
guinea pig LDLo oral 12500ug/kg (12.5mg/kg) LIVER: OTHER CHANGES

BLOOD: CHANGES IN SPLEEN

BLOOD: OTHER CHANGES
Virchows Archiv fuer Pathologische, Anatomie und Physiologie, und fuer Klinische Medizin. Vol. 320, Pg. 93, 1951.
hamster LD50 intraperitoneal 7300ug/kg (7.3mg/kg)   Medicina Experimentalis. Vol. 6, Pg. 101, 1962.
human LDLo intravenous 129ug/kg (0.129mg/kg) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

VASCULAR: SHOCK

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Human Toxicology. Vol. 2, Pg. 169, 1983.
human LDLo oral 86ug/kg (0.086mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: OTHER CHANGES
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 184, 1969.
human TDLo parenteral 710ug/kg (0.71mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

GASTROINTESTINAL: NAUSEA OR VOMITING
Archives of Internal Medicine. Vol. 137, Pg. 394, 1977.
man LDLo intravenous 143ug/kg/5D-I (0.143mg/kg) BLOOD: APLASTIC ANEMIA

MUSCULOSKELETAL: OTHER CHANGES
New England Journal of Medicine. Vol. 309, Pg. 310, 1983.
man LDLo oral 11mg/kg (11mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION

KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"
Canadian Medical Association Journal. Vol. 138, Pg. 335, 1988.
man TDLo oral 400ug/kg (0.4mg/kg) KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"

BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)"
Critical Care Medicine. Vol. 7, Pg. 278, 1979.
man TDLo oral 12514ug/kg/2Y (12.514mg/kg) BEHAVIORAL: MUSCLE WEAKNESS New England Journal of Medicine. Vol. 316, Pg. 1562, 1987.
mouse LD50 intramuscular 1197ug/kg (1.197mg/kg)   Journal of Medicinal Chemistry. Vol. 24, Pg. 257, 1981.
mouse LD50 intraperitoneal 1600ug/kg (1.6mg/kg)   Journal of Medicinal Chemistry. Vol. 28, Pg. 1204, 1985.
mouse LD50 intravenous 1700ug/kg (1.7mg/kg)   Drugs in Japan Vol. 6, Pg. 280, 1982.
mouse LD50 oral 5886ug/kg (5.886mg/kg)   National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986,
mouse LD50 subcutaneous 1200ug/kg (1.2mg/kg)   Drugs in Japan Vol. 6, Pg. 280, 1982.
pigeon LDLo unreported 30mg/kg (30mg/kg)   Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 27, Pg. 119, 1890.
quail LD50 oral 42mg/kg (42mg/kg)   Journal of Reproduction and Fertility. Vol. 48, Pg. 371, 1976.
rabbit LDLo intravenous 3mg/kg (3mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 67, Pg. 768, 1909.
rabbit LDLo oral 50mg/kg (50mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 67, Pg. 768, 1909.
rabbit LDLo subcutaneous 5mg/kg (5mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 67, Pg. 768, 1909.
rat LD50 intravenous 1600ug/kg (1.6mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: FOOD INTAKE (ANIMAL)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Toxicology and Applied Pharmacology. Vol. 13, Pg. 50, 1968.
rat LDLo intracrebral 1mg/kg (1mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: EXCITEMENT

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 109, Pg. 386, 1957.
rat LDLo intraperitoneal 1400ug/kg (1.4mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

MUSCULOSKELETAL: OTHER CHANGES

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Archives of Neurology Vol. 24, Pg. 72, 1971.
rat LDLo parenteral 1000ug/kg (1mg/kg)   Farmaco, Edizione Scientifica. Vol. 15, Pg. 533, 1960.
rat LDLo subcutaneous 4mg/kg (4mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 84, Pg. 257, 1950.
rat LDLo unreported 1mg/kg (1mg/kg)   "Principles of Insect Chemosterilization," Labrecque, G.C., and C.N. Smith, eds., New York, Appleton-Century-Crofts, 1968Vol. -, Pg. 315, 1968.
women LDLo intravenous 360ug/kg/6D (0.36mg/kg) KIDNEY, URETER, AND BLADDER: OTHER CHANGES

BLOOD: HEMORRHAGE
Nouvelle Presse Medicale. Vol. 9, Pg. 1587, 1980.
women LDLo oral 600ug/kg (0.6mg/kg) CARDIAC: OTHER CHANGES

BLOOD: APLASTIC ANEMIA
American Journal of Emergency Medicine. Vol. 16, Pg. 603, 1998.
women LDLo oral 3mg/kg (3mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

CARDIAC: OTHER CHANGES

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Japanese Journal of Toxicology. Vol. 12, Pg. 337, 1999.
women LDLo oral 8360ug/kg (8.36mg/kg) CARDIAC: OTHER CHANGES

KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Journal of Analytical Toxicology. Vol. 4, Pg. 153, 1980.
women TDLo oral 320ug/kg (0.32mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
Lancet. Vol. 2, Pg. 1271, 1987.
women TDLo oral 510ug/kg (0.51mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

GASTROINTESTINAL: NAUSEA OR VOMITING

BLOOD: APLASTIC ANEMIA
Human & Experimental Toxicology. Vol. 16, Pg. 229, 1997.
women TDLo oral 960ug/kg (0.96mg/kg) CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP New England Journal of Medicine. Vol. 322, Pg. 642, 1995.
women TDLo oral 1mg/kg (1mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

BLOOD: LEUKOPENIA
Journal of Toxicology, Clinical Toxicology. Vol. 33, Pg. 71, 1995.
women TDLo oral 4368ug/kg/26W (4.368mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Neurology. Vol. 41, Pg. 943, 1991.
 

Colchicine Consensus Reports

EPA Extremely Hazardous Substances List. EPA Genetic Toxicology Program. Reported in EPA TSCA Inventory.

Colchicine Safety Profile

A human poison by ingestion and intravenous routes. Poison experimentally by most routes. Human systemic effects: aplastic anemia, blood pressure depression, body temperature decrease, changes in kidney tubules, dyspnea, flaccid paralysis without anesthesia, gastrointestinal effects, kidney damage and hemorrhaging, muscle contraction or spasticity, muscle weakness, nausea or vomiting, respiratory stimulation, and somnolence. An experimental teratogen. Experimental reproductive effects. A severe eye irritant. Human mutation data reported. Inhibits the formation of microtubules and thus impairs cell division. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes: VeryT+,ToxicT
Risk Statements: 26/28 
R26/28:Very toxic by inhalation and if swallowed.
Safety Statements: 13-45 
S13:Keep away from food, drink and animal foodstuffs. 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 1544 6.1/PG 1
WGK Germany: 3
RTECS: GH0700000
HazardClass: 6.1
PackingGroup: I

Colchicine Specification

  Colchicine (CAS NO.64-86-8), its Synonyms are 7-alpha-H-Colchicine ; 7alphaH-Colchicine ; AI3-31149 ; Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)- ; Benzo(a)heptalen-9(5H)-one, 7-acetamido-6,7-dihydro-1,2,3,10-tetramethoxy- ; Acetamide, N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)- ; Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)- . It is odorless or nearly odorless pale yellow needles or powder that darkens on exposure to light.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View